Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene
- PMID: 6504162
- DOI: 10.1038/312545a0
Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene
Abstract
A variety of antigens have been identified on the surface of the malignant cell. However, identical antigens are often found on non-malignant cells of the same or different histological origin, or of a different stage of embryonic development. Many of these tumour-associated antigens appear to be only incidentally expressed on neoplastic cells. Clearly, it would be of great interest to identify cell-surface antigens whose expression is associated specifically with the transformed state and linked directly with the mechanisms responsible for transformation. The detection of activated cellular oncogenes in human and animal cancer cells by the technique of DNA transfection has allowed the isolation of genetic elements which are thought to have a critical role in malignancy. Here, in an effort to identify cell-surface antigens associated with the neoplastic process, we have generated hybridomas which secrete monoclonal antibodies that react specifically with cell-surface determinants found on NIH 3T3 cells transformed by transfection with a group of rat neuroblastoma oncogenes. These antibodies bind to and immunoprecipitate a phosphoprotein of relative molecular mass 185,000 (185 K) from a DNA donor rat neuroblastoma and 13 independent rat neuroblastoma DNA transfectants. There was no antibody reactivity with normal NIH 3T3 cells or with NIH 3T3 cells transformed by various other agents.
Similar articles
-
A novel approach to production of antitumor monoclonal antibodies: antibody to a cell surface glycoprotein associated with transformation by a human oncogene.Surgery. 1984 Aug;96(2):264-72. Surgery. 1984. PMID: 6379959
-
Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies.Cell. 1985 Jul;41(3):697-706. doi: 10.1016/s0092-8674(85)80050-7. Cell. 1985. PMID: 2860972
-
Expression of Ly-6.2 and Thy-1 antigens on NIH 3T3 cells suppressed after transformation with activated human ras-oncogenes.Int J Cancer. 1986 Oct 15;38(4):575-80. doi: 10.1002/ijc.2910380418. Int J Cancer. 1986. PMID: 2875953
-
Malignant transformation of human fibroblasts by oncogene transfection or carcinogen treatment.Prog Clin Biol Res. 1990;340D:195-205. Prog Clin Biol Res. 1990. PMID: 2196579 Review.
-
Immunogenicity and involvement in the host's effector mechanisms of the oncogene--induced transformation--associated cell surface antigens.In Vivo. 1991 Nov-Dec;5(6):663-70. In Vivo. 1991. PMID: 1810453 Review.
Cited by
-
EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions.EMBO J. 1988 Apr;7(4):995-1001. doi: 10.1002/j.1460-2075.1988.tb02906.x. EMBO J. 1988. PMID: 3261240 Free PMC article.
-
Stage- and tissue-specific expression of the neu oncogene in rat development.Proc Natl Acad Sci U S A. 1987 Dec;84(23):8498-501. doi: 10.1073/pnas.84.23.8498. Proc Natl Acad Sci U S A. 1987. PMID: 3317411 Free PMC article.
-
The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade.Proc Natl Acad Sci U S A. 1990 Aug;87(16):6054-7. doi: 10.1073/pnas.87.16.6054. Proc Natl Acad Sci U S A. 1990. PMID: 1974718 Free PMC article.
-
Immunologic approaches to inhibiting cell-surface-residing oncoproteins in human tumors.Immunol Res. 1998;17(1-2):179-89. doi: 10.1007/BF02786443. Immunol Res. 1998. PMID: 9479580 Review.
-
A Comprehensive Review of HER2 in Cancer Biology and Therapeutics.Genes (Basel). 2024 Jul 11;15(7):903. doi: 10.3390/genes15070903. Genes (Basel). 2024. PMID: 39062682 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical